Asset Details
Do you wish to reserve the book?
A Tenon’s capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Tenon’s capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Do you wish to request the book?
A Tenon’s capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Tenon’s capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
2020
Overview
Glaucoma filtration surgery is one of the most effective methods for lowering intraocular pressure in glaucoma. The surgery efficiently reduces intra-ocular pressure but the most common cause of failure is scarring at the incision site. This occurs in the conjunctiva/Tenon's capsule layer overlying the scleral coat of the eye. Currently used antimetabolite treatments to prevent post-surgical scarring are non-selective and are associated with potentially blinding side effects. Developing new treatments to target scarring requires both a better understanding of wound healing and scarring in the conjunctiva, and new means of delivering anti-scarring drugs locally and sustainably. By combining plastic compression of collagen gels with a soft collagen-based layer, we have developed a physiologically relevant model of the sub-epithelial bulbar conjunctiva/Tenon's capsule interface, which allows a more holistic approach to the understanding of subconjunctival tissue behaviour and local drug delivery. The biomimetic tissue hosts both primary human conjunctival fibroblasts and an immune component in the form of macrophages, morphologically and structurally mimicking the mechanical proprieties and contraction kinetics of ex vivo porcine conjunctiva. We show that our model is suitable for the screening of drugs targeting scarring and/or inflammation, and amenable to the study of local drug delivery devices that can be inserted in between the two layers of the biomimetic. We propose that this multicellular-bilayer engineered tissue will be useful to study complex biological aspects of scarring and fibrosis, including the role of inflammation, with potentially significant implications for the management of scarring following glaucoma filtration surgery and other anterior ocular segment scarring conditions. Crucially, it uniquely allows the evaluation of new means of local drug delivery within a physiologically relevant tissue mimetic, mimicking intraoperative drug delivery in vivo.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Cicatrix - prevention & control
/ Collagen
/ Drug Delivery Systems - methods
/ Drug Evaluation, Preclinical - methods
/ Fibrosis
/ Filtering Surgery - adverse effects
/ Gels
/ Glaucoma
/ Humans
/ Intraoperative Care - methods
/ Medicine and Health Sciences
/ Methods
/ Mimicry
/ Postoperative Complications - etiology
/ Postoperative Complications - pathology
/ Postoperative Complications - prevention & control
/ Scars
/ Surgery
/ Swine
/ Tenon Capsule - drug effects
/ Tissues
